ArticleBMC neurology2025
Conus medullaris and cauda equina syndrome as complications of non-imaging guided epidural steroid injection: two case reports with comprehensive interdisciplinary work-up.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionEpidural steroid injection (ESI) is commonly performed in the outpatient setting for relieving lumbosacral radicular pain, i.e., sciatica. Neurological and neuro-urological adverse events are rare but devastating when occurring. This led to a warning of the U.S. Food and Drug Administration about the use of corticosteroids in the spine. Reviews on causes and numbers of complications are lacking. CASE PRESENTATION: Two cases from our tertiary spine center who sustained conus medullaris and cauda equina syndrome following ESI in a secondary care setting not affiliated with our institution. Both patients received ESI for the treatment of chronic lower back pain without sciatica and any reported neurological impairment prior to the injection. In both Case 1 (F, 72yrs) and Case 2 (F, 72yrs), ESI was administered without imaging-guidance and without pre-interventional lumbar MRI. We assessed both patients by thorough neurological examination, comprehensive neuroimaging, neurophysiology, and neuro-urological assessments. Case 1 had cauda equina syndrome, arachnoiditis was diagnosed from lumbar MRI. Case 2 had conus medullaris syndrome probably related to a reported accidental dura puncture. Symptoms of lumbosacral sensory impairment partly recovered, motor symptoms recovered, but neurogenic lower urinary tract and bowel dysfunction persisted. One patient still requires intermittent self-catheterization, while the other patient suffers from bowel dysfunction at 2-yr follow up. DISCUSSION: Although neurological complications from ESI are rarely reported they can be associated with serious long-term impairments. Comprehensive diagnostic work-up is required to discern potential underlying pathomechanisms and to quantify neural damage load. Neuro-urological diagnostics is required to reveal bladder-bowel dysfunction, install proper management and to prevent secondary complications. We advocate imaging-guidance in ESI to reduce the rate of neurological complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.